OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
Nika Kianfar, Shayan Dasdar, Ali Salehi Farid, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Nika Kianfar, Shayan Dasdar, Ali Salehi Farid, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Showing 7 citing articles:
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review
Po‐Chien Wu, I‐Hsin Huang, Ching-Ya Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 465-465
Open Access | Times Cited: 2
Po‐Chien Wu, I‐Hsin Huang, Ching-Ya Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 465-465
Open Access | Times Cited: 2
COVID-19 and autoimmune bullous diseases: Lessons learned
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Adverse outcome and severity of COVID ‐19 in patients with autoimmune bullous diseases: A historical cohort study
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 10
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 10
A Rare Case of COVID-19-Induced Acute Exacerbation of Oral Dermatitis Herpetiformis in a Geriatric Patient
Amira Shafuria, Irna Sufiawati, Hermin Aminah Usman
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 129-134
Open Access
Amira Shafuria, Irna Sufiawati, Hermin Aminah Usman
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 129-134
Open Access
A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals
Tassahil Messas, Rachel Lim, Laura Burns, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access
Tassahil Messas, Rachel Lim, Laura Burns, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access
